Biotech Bulls & Breakthroughs podcast: The Future of Biomanufacturing with Michael Heltzen
press clippings
Biotech Bulls & Breakthroughs podcast: The Future of Biomanufacturing with Michael HeltzenApril 13, 2026
Grow Everything podcast featuring Damien Perriman
press releasenutraceuticalsmedicinepress clippingsscience
eXoZymes CCO, Damien Perriman, outlines NCTx strategy and the commercial path for cell-free biomanufacturing on Grow Everything podcastApril 10, 2026
The Metabolic Engine - How Scientists Are Exploring a New Path Beyond GLP-1 Weight-Loss Drugs
nutraceuticalspress clippings
Village Voice: The Metabolic Engine - How Scientists Are Exploring a New Path Beyond GLP-1 Weight-Loss DrugsApril 9, 2026
Perriman at Nasdaq
investornutraceuticalsmedicinepress clippingsvideo
Nasdaq: Damien Perriman interview on NCTApril 2, 2026
Transcript: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026
investor
Transcript: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026April 1, 2026
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
press releaseinvestor
eXoZymes Provides Fourth Quarter and Full Year 2025 UpdateMarch 31, 2026
NLR: Why Use Living Cells?
biofuelmedicinepress clippingsscience
NLR: Why Use Living Cells? NLR Is Making Chemicals With Enzymes AloneMarch 26, 2026
Q4 + 2025 investor call
investor
Sign up: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026March 25, 2026
SynBioBeta: Successful pilot scale run
press clippings
SynBioBeta: Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalabilityMarch 21, 2026
Business Insider
press clippings
Business Insider: eXoZymes announces validation milestone for its biomanufacturing platformMarch 20, 2026
Previous page
Page 1 of 12
Next page